How has been the historical performance of Trident Texofab?

Jun 30 2025 10:40 PM IST
share
Share Via
Trident Texofab has shown steady growth in net sales, increasing from 49.93 crore in March 2021 to 122.06 crore in March 2025, with a profit after tax of 2.51 crore. Key financial metrics indicate a positive trend in revenue and profitability over the years.
Answer:
The historical performance of Trident Texofab shows a steady growth in net sales and profitability over the years, with the most recent figures for March 2025 indicating net sales of 122.06 crore and a profit after tax of 2.51 crore.

Breakdown:
Trident Texofab's net sales have increased from 49.93 crore in March 2021 to 122.06 crore in March 2025, reflecting a consistent upward trend. The total operating income followed a similar trajectory, rising from 84.29 crore in March 2022 to 122.06 crore in March 2025. The company's total expenditure, excluding depreciation, also grew, reaching 116.58 crore in March 2025, up from 47.05 crore in March 2021. Operating profit, excluding other income, peaked at 5.48 crore in March 2025, while the overall operating profit (PBDIT) reached 8.78 crore in the same period. Profit before tax saw fluctuations but ultimately rose to 2.58 crore in March 2025, contributing to a profit after tax of 2.51 crore. The earnings per share increased to 1.85 in March 2025, indicating improved shareholder value. Overall, the company's financial metrics demonstrate a positive trend in revenue generation and profitability over the years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Trident Texofab falling/rising?
Dec 12 2025 01:10 AM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Nov 19 2025 08:10 AM IST
share
Share Via